Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 7.6% | 8.7% | 0.3% | 7.0% | 9.7% | 9.1% | 6.7% | 6.4% | 12.3% | 1.3% | 1.7% | 3.7% | 7.2% | (4.7%) | 0.1% | 2.8% | 4.9% | 9.1% | 7.1% | 4.0% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is 4.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Abbott Laboratories have been 6.7% over the past three years, and 6.0% over the past five years.
As of today, Abbott Laboratories's ROIC - WACC is 4.6%, which is higher than industry median of (64.5%). It indicates that Abbott Laboratories's ROIC - WACC is Good.